Core Viewpoint - Chengdu Zongheng Automation Technology Co., Ltd. disclosed its regulatory history over the past five years, indicating no penalties but several warnings and regulatory measures from the China Securities Regulatory Commission (CSRC) and the Shanghai Stock Exchange (SSE) [1] Regulatory Measures and Rectification - The CSRC issued two warning letters and two regulatory concern letters, while the SSE provided two oral warnings and one regulatory warning, all related to issues such as improper revenue recognition and inadequate disclosure of fundraising management [2][3] - Specific issues included the recognition of revenue of 14.64 million yuan in the wrong period, failure to capitalize certain R&D expenses amounting to 1.49 million yuan, and inaccuracies in the disclosure of fundraising replacement timing [2] - The company, along with its chairman and financial director, received warnings and has submitted rectification reports, committing to enhance legal compliance and internal controls [2] Additional Regulatory Concerns - Further concerns raised by the CSRC included lack of meeting records, non-compliance in account usage and accounting vouchers, and insufficient assessment of inventory net realizable value [3] - The company has completed self-inspection and rectification, reporting the results to the regulatory body [3] Recent Warnings - In late 2024, the CSRC and SSE issued warnings regarding insufficient provision for bad debts amounting to 2.226 million yuan and premature revenue recognition of 2.076 million yuan [4] - The company has implemented corrective measures and submitted a report following these warnings [4] Information Disclosure Issues - The SSE issued a warning in August 2025 due to the company's repeated requests for extensions in responding to inquiries about its 2023 annual report, violating timely disclosure regulations [5] - The company has conducted a self-inspection and implemented corrective actions in response to these issues [5]

Core Viewpoint - Wuzhou Transportation (600368.SH) has completed all rectifications in response to the Guangxi Securities Regulatory Bureau's findings regarding accounting irregularities and failure to conduct integrity checks on proposed directors and supervisors [1][2] Group 1: Accounting Issues - The company received a corrective order from the Guangxi Securities Regulatory Bureau on November 20, 2025, requiring rectification within 30 days [1] - Between 2022 and 2024, the company had insufficient basis for revenue recognition and incorrectly applied the gross method for revenue recognition, leading to inaccurate financial disclosures [1] - The company has corrected prior accounting errors by changing the revenue recognition method from gross to net, resulting in restated financial reports for 2022, 2023, and 2024 [1] Group 2: Financial Adjustments - After adjustments, the 2022 revenue decreased from approximately 1.687 billion to about 1.501 billion, and the operating costs fell from around 816 million to about 630 million [1] - For 2023, revenue was revised down from approximately 1.633 billion to about 1.617 billion, with operating costs adjusted from around 652 million to about 636 million [1] - In 2024, revenue was reduced from approximately 1.823 billion to about 1.563 billion, and operating costs decreased from around 922 million to about 662 million [1] Group 3: Integrity Checks - The company failed to conduct required integrity checks on proposed directors and supervisors from 2022 to 2024, violating the Securities and Futures Market Integrity Supervision Management Measures [2] - The company has now completed supplementary integrity checks for current directors and supervisors and will standardize the execution of related processes to prevent recurrence of similar issues [2]

Group 1 - The core issue identified by the Shenzhen Stock Exchange is the company's inadequate internal control and non-compliance with accounting standards, leading to discrepancies in contract execution and revenue recognition [1] - Specific problems include improper revenue recognition by a subsidiary, insufficient impairment testing of fixed assets, and inadequate assessment of goodwill impairment [1] - The company has been warned to take corrective actions to prevent recurrence of these issues, with specific responsibilities assigned to key executives [1] Group 2 - For the first half of 2025, the company's revenue composition shows that software and information technology services account for 99.65% of total revenue, indicating a strong focus on this sector [2] - As of the latest report, the company's market capitalization stands at 5.3 billion yuan [3]

Core Viewpoint - Rongjie Health Technology Co., Ltd. has received an administrative regulatory measure from the Anhui Securities Regulatory Bureau due to issues related to accounting irregularities, inaccurate information disclosure, and improper use of raised funds [1][2]. Group 1: Accounting Irregularities - The company has been found to have accounting irregularities, particularly in revenue recognition, where sales are recognized at the point of shipment, inconsistent with the revenue recognition policy disclosed in the annual report [1]. - The consolidated financial statements did not write off the revaluation surplus of investment properties held by subsidiaries, leading to an inflated balance of 2.2509 million yuan in the "Investment Properties" account for the years 2022-2024 [1]. Group 2: Inaccurate Information Disclosure - The company’s 2024 annual report and financial statement notes contain multiple errors and omissions, including inconsistencies in the amounts disclosed for "assets and liabilities measured at fair value" and inaccuracies in the disclosure of "foreign currency monetary items" [2]. - There were also discrepancies in the reported reduction amounts for "fixed assets - office and other equipment" and failure to disclose changes in accounting estimates for "other receivables" as required [2]. Group 3: Improper Use of Raised Funds - The company has been cited for improper use of raised funds and inaccurate related disclosures, violating regulatory requirements outlined in the "Guidelines for the Management and Use of Raised Funds by Listed Companies" [2]. - The Anhui Securities Regulatory Bureau has mandated the company to rectify these issues within 30 days of receiving the decision and submit a written report [2].

Core Viewpoint - The company, Yunda Technology, has received a warning from the China Securities Regulatory Commission for various internal control and accounting issues that violate regulatory standards [1][2]. Group 1: Internal Control Issues - The company has inadequate internal control execution, with discrepancies between contract acceptance criteria and actual acceptance, as well as missing logistics documents for several projects from 2019 to 2023 [1]. Group 2: Accounting Irregularities - There are several accounting irregularities identified: - In 2020, a subsidiary, Sichuan Huiyou Electric Co., Ltd., recognized revenue prematurely and inappropriately under the total amount method, violating accounting standards [2]. - From 2021 to 2023, the company failed to recognize impairment for certain fixed assets despite clear signs of impairment [2]. - Insufficient basis for goodwill impairment testing was noted in 2022, where significant deviations from performance commitments occurred without timely third-party testing [2]. - The allocation of labor costs and R&D expenses was deemed unreasonable, not aligning with regulatory guidelines [2]. - Incorrect accounting treatment for the write-off of estimated liabilities was observed during the performance commitment period from 2018 to 2020 [2].

Core Viewpoint - The company, Yunda Technology, has received a warning from the China Securities Regulatory Commission regarding several compliance issues related to internal controls and accounting practices [1][2]. Group 1: Internal Control Issues - The company has been found to have inadequate internal control execution, with discrepancies between contract acceptance criteria and actual acceptance, as well as missing logistics documents for certain projects [1]. Group 2: Accounting Irregularities - The company’s subsidiary, Sichuan Huiyou Electric Co., Ltd., improperly recognized revenue using the total amount method for trade transactions without holding control over the goods, violating accounting standards [2]. - There has been insufficient impairment recognition for fixed assets, with significant impairment indicators present but not accounted for as of 2023 [2]. - The goodwill impairment testing was not adequately supported, as the company failed to conduct timely assessments despite indications of potential impairment [2]. - The allocation of labor costs and R&D expenses has been deemed unreasonable, not aligning with regulatory guidelines [2]. - The company incorrectly handled the write-off of estimated liabilities during the performance commitment period, violating consistency principles in accounting treatment [2].

Core Viewpoint - Rongjie Health (300247.SZ) has been ordered by the Anhui Regulatory Bureau of the China Securities Regulatory Commission to rectify its operations due to several violations, including improper accounting practices and inaccurate information disclosure. Group 1: Accounting Issues - The company has been found to have non-compliant accounting practices, with revenue from major product sales recognized at the point of shipment, inconsistent with the revenue recognition policy disclosed in the annual report [1] - The consolidated financial statements failed to write off the revaluation surplus of investment properties held by subsidiaries, resulting in an inflated "Investment Properties" account by 2.2509 million yuan for the years 2022-2024 [1] Group 2: Information Disclosure Issues - The 2024 annual report and financial statement notes contain multiple errors and omissions, including inconsistencies in the amounts disclosed for "assets and liabilities measured at fair value" [1] - The reduction in the book value of "Fixed Assets - Office and Other Equipment" was less than the reduction in accumulated depreciation for the current period [1] - Inaccuracies were noted in the disclosure of "foreign currency monetary items" and the failure to disclose changes in accounting estimates for "other receivables" as required [1][2] Group 3: Fundraising Issues - The company has been cited for improper use of raised funds and inaccuracies in the disclosure of fundraising information [2]

Core Viewpoint - Wuzhou Transportation has been subjected to administrative regulatory measures by the Guangxi Securities Regulatory Bureau due to accounting irregularities and failure to fulfill obligations regarding the integrity records of proposed directors and senior management [1][3][6] Group 1: Regulatory Actions - The company was ordered to rectify its accounting practices and was subjected to regulatory talks involving its former chairman and senior management [1][3] - The Guangxi Securities Regulatory Bureau found that Wuzhou Transportation's financial reports for 2022 to 2024 contained inaccuracies due to improper revenue recognition methods [3][6] Group 2: Financial Performance - For the years 2022 to 2024, the company's revenue from its commercial logistics business was reported as 5.35 billion, 2.91 billion, and 5.69 billion respectively, with year-on-year growth rates of 6.96%, -44.94%, and 95.21% [3] - In the first three quarters of the current year, Wuzhou Transportation achieved revenue of 1.205 billion, a decrease of 0.86% year-on-year, and a net profit of 508 million, down 10.26% year-on-year [7] Group 3: Business Operations - The company has been expanding its commercial business, including products like ginger, garlic, sugar, and dairy, leading to an increase in revenue [4] - Wuzhou Transportation's commercial logistics business is a significant segment, second only to its toll road operations, and has been affected by market demand fluctuations [4][5]

Core Viewpoint - Guangxi Wuzhou Transportation Co., Ltd. has received administrative regulatory measures from the Guangxi Securities Regulatory Bureau due to issues related to accounting irregularities and failure to fulfill obligations regarding the integrity records of proposed directors and senior management [1][2][3] Group 1: Regulatory Findings - The company has been found to have non-compliant accounting practices, specifically in the recognition of revenue from its commercial operations between 2022 and 2024, leading to inaccurate financial reporting [1][4] - The company failed to conduct integrity record checks for proposed directors and senior management during the same period, violating relevant regulations [2][4] Group 2: Required Actions - The company is mandated to enhance the legal and regulatory training for all directors and senior management to improve their performance and compliance with information disclosure and internal control [2][5] - The company must strengthen its financial accounting practices to ensure the quality of financial reporting and rectify the identified issues within 30 days of receiving the regulatory decision [2][5] Group 3: Accountability - The former chairman, general manager, and chief accountant of the company are held primarily responsible for the violations and are subject to regulatory discussions [3][4] - The company acknowledges the issues raised and commits to a thorough review and improvement of its compliance with relevant laws and regulations [5][6]

Core Viewpoint - Wuzhou Transportation (600368) has received regulatory measures from the Guangxi Securities Regulatory Bureau due to issues related to accounting irregularities and failure to conduct integrity checks on proposed senior management appointments [2][3] Group 1: Regulatory Actions - The Guangxi Securities Regulatory Bureau issued a corrective order to Wuzhou Transportation and initiated regulatory talks with responsible individuals [2][3] - The company is required to submit a rectification report within a specified timeframe [4] Group 2: Identified Issues - Wuzhou Transportation's accounting practices were found to be non-compliant, with insufficient basis for revenue recognition in its trading business from 2022 to 2024, leading to inaccurate financial disclosures [3] - The company failed to conduct required integrity checks on proposed directors and senior management, violating relevant regulations [3] Group 3: Company Operations and Financial Performance - Wuzhou Transportation is the only listed company in Guangxi operating toll road businesses, managing highways and engaging in logistics and asset management [5] - For the first three quarters of 2025, the company reported revenues of 1.205 billion yuan, a year-on-year decrease of 0.86%, and a net profit of 508 million yuan, down 10.26% from the previous year [5]